On the estimation of total variability in assay validation.

Area of Science:

• Pharmaceutical Science
• Statistical Modeling
• Analytical Chemistry

Background:

• Assay validation in the pharmaceutical industry requires meeting acceptable limits for accuracy and precision.
• Estimating total variability is crucial for assessing assay precision.
• One-way random effects models are commonly used in assay validation.

Purpose of the Study:

• To propose a general class of estimators for assay precision.
• To derive an optimal estimator with the smallest mean squared error.
• To evaluate the performance of the proposed estimators through simulation.

Main Methods:

• Utilizing a one-way random effects model for assay validation.
• Developing a general class of estimators, including analysis of variance and maximum likelihood estimators.
• Deriving an optimal estimator based on minimum mean squared error.
• Conducting Monte Carlo simulations to assess finite sample performance.

Main Results:

• A novel class of estimators for assay precision was proposed.
• An optimal estimator within this class was identified and an approximate version considered.
• Monte Carlo simulations demonstrated the finite sample performance of the proposed estimators.
• The methodology was illustrated with two practical examples.

Conclusions:

• The proposed methodology provides a robust approach to assessing assay precision in pharmaceutical validation.
• The optimal estimator offers improved accuracy in estimating total assay variability.
• The findings contribute to more reliable and efficient drug development processes.